✦ LIBER ✦

Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score

✍ Scribed by Hwai-I Yang; Man-Fung Yuen; Henry Lik-Yuen Chan; Kwang-Hyub Han; Pei-Jer Chen; Do-Young Kim; Sang-Hoon Ahn; Chien-Jen Chen; Vincent Wai-Sun Wong; Wai-Kay Seto

Book ID: 117785630
Publisher: The Lancet
Year: 2011
Tongue: English
Weight: 205 KB
Volume: 12
Category: Article
ISSN: 1470-2045
DOI: 10.1016/s1470-2045(11)70077-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Independent risk factors and predictive

Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B

✍ Man-Fung Yuen; Yasuhito Tanaka; Daniel Yee-Tak Fong; James Fung; Danny Ka-Ho Won 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 202 KB

678 INDEPENDENT RISK FACTORS AND PREDICT

678 INDEPENDENT RISK FACTORS AND PREDICTIVE SCORE FOR THE DEVELOPMENT OF HEPATOCELLULAR CARCINOMA IN CHRONIC HEPATITIS B

✍ M.F. Yuen; Y. Tanaka; D.Y. Fong; J. Fung; D.K. Wong; J.C. Yuen; D.Y. But; A.O. C 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Risk assessment for hepatocellular carci

Risk assessment for hepatocellular carcinoma in chronic hepatitis B: scores and surveillance

✍ S. A. Gonzalez; E. B. Keeffe 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

461 INTEGRATING QUANTITIATIVE SERUM HBSA

461 INTEGRATING QUANTITIATIVE SERUM HBSAG LEVELS INTO RISK SCORES FOR PREDICTING HEPATOCELLULAR CARCINOMA IN CHRONIC HEPATITIS B PATIENTS

✍ C.-J. Chen; M.-H. Lee; H.-I. Yang; J. Liu; R. Batrla-Utermann; C.-L. Jen; U.H. I 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Does interferon therapy for chronic hepa

Does interferon therapy for chronic hepatitis B reduce the risks of developing cirrhosis and hepatocellular carcinoma?

✍ Anna S. F. Lok 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 413 KB

Objective: To estimate the cost-effectiveness of interferon-a2B for the treatment of patients with chronic hepatitis B infection who are positive for hepatitis B e antigen (HBeAg). Design: Meta-analysis of nine randomized controlled trials and cost-effectiveness analysis, projecting the clinical an

375 GENERATION OF THE PREDICTION MODELS

375 GENERATION OF THE PREDICTION MODELS FOR THE DEVELOPMENT OF HEPATOCELLULAR CARCINOMA IN CHRONIC HEPATITIS B AND EXTERNAL VALIDATION BY INDEPENDENT COHORTS

✍ M. Kurosaki; M.-F. Yuen; W.-K. Seto; T. Kumada; K. Tanaka; Y. Suzuki; Y. Hoshiok 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 56 KB